Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fipamezole in Neurogenic Orthostatic Hypotension (Foehn)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2008 by Juvantia Pharma Ltd.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Santhera Pharmaceuticals
Information provided by:
Juvantia Pharma Ltd
ClinicalTrials.gov Identifier:
NCT00758849
First received: September 24, 2008
Last updated: September 30, 2008
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: May 2009
  Estimated Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)